ECSP088138A - Nuevo procedimiento para preparar sales de tiotropio - Google Patents

Nuevo procedimiento para preparar sales de tiotropio

Info

Publication number
ECSP088138A
ECSP088138A EC2008008138A ECSP088138A ECSP088138A EC SP088138 A ECSP088138 A EC SP088138A EC 2008008138 A EC2008008138 A EC 2008008138A EC SP088138 A ECSP088138 A EC SP088138A EC SP088138 A ECSP088138 A EC SP088138A
Authority
EC
Ecuador
Prior art keywords
salts
tiotrope
prepare
new procedure
new
Prior art date
Application number
EC2008008138A
Other languages
English (en)
Inventor
Joerg Brandenburg
Waldemar Pfrengle
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP088138A publication Critical patent/ECSP088138A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención se refiere a un nuevo procedimiento para preparar sales de tiotropio de fórmula general (I) (I)en las cuales X - puede tener los significados que se mencionan en las reivindicaciones y en la memoria descriptiva.
EC2008008138A 2005-07-27 2008-01-25 Nuevo procedimiento para preparar sales de tiotropio ECSP088138A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005035112A DE102005035112A1 (de) 2005-07-27 2005-07-27 Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen

Publications (1)

Publication Number Publication Date
ECSP088138A true ECSP088138A (es) 2008-02-20

Family

ID=37110331

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008138A ECSP088138A (es) 2005-07-27 2008-01-25 Nuevo procedimiento para preparar sales de tiotropio

Country Status (24)

Country Link
US (5) US20070027320A1 (es)
EP (2) EP1910354B1 (es)
JP (1) JP5210861B2 (es)
KR (1) KR101299929B1 (es)
CN (2) CN104356129A (es)
AR (1) AR057690A1 (es)
AU (1) AU2006274012B2 (es)
BR (1) BRPI0614062B8 (es)
CA (1) CA2616222C (es)
DE (1) DE102005035112A1 (es)
DK (1) DK1910354T3 (es)
EA (1) EA014271B1 (es)
EC (1) ECSP088138A (es)
ES (1) ES2613952T3 (es)
HU (1) HUE032259T2 (es)
IL (1) IL188989A (es)
MX (1) MX2008001093A (es)
NO (2) NO340877B1 (es)
NZ (1) NZ566039A (es)
PL (1) PL1910354T3 (es)
TW (3) TWI486345B (es)
UA (1) UA94914C2 (es)
WO (1) WO2007012626A2 (es)
ZA (1) ZA200711113B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089852A1 (de) * 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
EP1997819A1 (de) * 2007-05-25 2008-12-03 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopinestern
EP2036898A2 (de) * 2007-09-13 2009-03-18 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von 1,3-Dioxolan-2Onen sowie von Carbonsäureestern durch Transacylierung unter Basischen Reaktionsbedingungen
WO2009087419A1 (en) * 2008-01-10 2009-07-16 Generics [Uk] Limited Novel process for the preparation of scopine esters
CA2768553C (en) 2009-08-07 2016-08-02 Generics [Uk] Limited Anhydrate of tiotropium bromide
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
CZ305012B6 (cs) * 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu
WO2021133280A1 (en) * 2019-12-27 2021-07-01 Deva Holding An improved process for preparation of scopine hydrobromide

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US7441045B2 (en) * 1999-12-13 2008-10-21 F5 Networks, Inc. Method and system for balancing load distribution on a wide area network
US6934686B1 (en) 2000-06-30 2005-08-23 I2 Technologies Us, Inc. Warranty transaction system and method
US7574499B1 (en) * 2000-07-19 2009-08-11 Akamai Technologies, Inc. Global traffic management system using IP anycast routing and dynamic load-balancing
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US7237017B1 (en) * 2001-03-13 2007-06-26 Panamsat Corporation Micronode in a satellite based content delivery system
AU2002338270A1 (en) * 2001-04-02 2002-10-15 Akamai Technologies, Inc. Scalable, high performance and highly available distributed storage system for internet content
WO2002096423A2 (en) * 2001-05-25 2002-12-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
JP4160506B2 (ja) * 2001-09-28 2008-10-01 レヴェル ３ シーディーエヌ インターナショナル インコーポレーテッド． 構成可能な適応型広域トラフィック制御および管理
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7305429B2 (en) * 2002-06-10 2007-12-04 Utstarcom, Inc. Method and apparatus for global server load balancing
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DK1682541T3 (da) * 2003-11-03 2010-06-28 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af tiotropiumsalte
DK1682543T3 (da) * 2003-11-03 2010-12-13 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af nye tiotropiumsalte
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
KR20080024532A (ko) * 2005-06-15 2008-03-18 베링거 인겔하임 인터내셔날 게엠베하 신규한 티오트로퓸 염의 제조방법, 신규한 티오트로퓸 염및 이의 약제학적 조성물

Also Published As

Publication number Publication date
AR057690A1 (es) 2007-12-12
TWI443097B (zh) 2014-07-01
JP5210861B2 (ja) 2013-06-12
ES2613952T3 (es) 2017-05-29
DE102005035112A1 (de) 2007-02-15
CN104356129A (zh) 2015-02-18
EA200800324A1 (ru) 2008-08-29
ZA200711113B (en) 2010-08-25
EP1910354A2 (de) 2008-04-16
TW200738704A (en) 2007-10-16
NO20170613A1 (no) 2008-02-13
EA014271B1 (ru) 2010-10-29
WO2007012626A2 (de) 2007-02-01
PL1910354T3 (pl) 2017-04-28
IL188989A0 (en) 2008-08-07
IL188989A (en) 2012-10-31
TWI486346B (zh) 2015-06-01
TW201418252A (zh) 2014-05-16
NZ566039A (en) 2011-07-29
KR101299929B1 (ko) 2013-08-27
CN101309920A (zh) 2008-11-19
EP1910354B1 (de) 2016-11-09
US20150225395A1 (en) 2015-08-13
UA94914C2 (ru) 2011-06-25
MX2008001093A (es) 2008-03-11
KR20080032634A (ko) 2008-04-15
US20070027320A1 (en) 2007-02-01
BRPI0614062A2 (pt) 2011-03-09
BRPI0614062B8 (pt) 2021-05-25
CA2616222A1 (en) 2007-02-01
US20140323732A1 (en) 2014-10-30
EP3153512A1 (de) 2017-04-12
WO2007012626A3 (de) 2010-05-06
BRPI0614062B1 (pt) 2020-11-17
US20130116435A1 (en) 2013-05-09
NO340877B1 (no) 2017-07-03
NO20076681L (no) 2008-02-13
US20100210844A1 (en) 2010-08-19
JP2009507769A (ja) 2009-02-26
DK1910354T3 (en) 2017-02-13
TWI486345B (zh) 2015-06-01
TW201418253A (zh) 2014-05-16
CA2616222C (en) 2014-09-23
HUE032259T2 (en) 2017-09-28
AU2006274012A1 (en) 2007-02-01
AU2006274012B2 (en) 2011-11-03

Similar Documents

Publication Publication Date Title
ECSP077248A (es) Procedimiento para la preparación de dihidropteridinonas
ECSP10010245A (es) Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i
CR20140275A (es) Triazolopiridinas sustituidas
ECSP099721A (es) Inhibidores de cinasa p70 s6
MX381849B (es) Compuestos a base de pirazol[1,5-a]pirimidina, composiciones que los comprenden, y métodos para su uso.
NI200900032A (es) Compuestos de pirido (2, 3-d) pirimidinonay su uso como inhibidores de pi3
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
DOP2010000191A (es) Derivados bis-(sulfonilamino)
CR11333A (es) cis-IMIDAZOLINAS QUIRALES
CR20110279A (es) Derivados de piridina y pirimidina como inhibidores de fosfodiesterasa 10
AR069531A1 (es) Derivados de indolinona y procedimiento para su fabricacion
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
CR11548A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
CR20120264A (es) Compuestos
ECSP11011391A (es) Métodos y productos intermedios para preparar agentes farmacéuticos
CR10573A (es) Derivados del pirazol como inhibidores del citocromo p450
NI200900052A (es) Heterocíclicos derivados de los inhibidores de metaloproteasa
ECSP088140A (es) Nuevos análogos de piridina
CU20110220A7 (es) Espiro-epóxidos como productos intermedios
AR083268A1 (es) Conjugado de naloxol-peg cristalino
UY29742A1 (es) Procedimiento para la preparación de betamimeticos
UY32635A (es) Derivados de bis-(sulfonilamino) en terapia 735
UY29325A1 (es) Nuevos derivados de 2 - amino-piridina
UY30865A1 (es) Nuevos analogos de piridina x 161